
Release date: 2024-08-26 17:21:03 Article From: Lucius Laos Recommended: 372
As the first PI3Kα inhibitor, Alpelisib has shown significant efficacy in the treatment of HR/HER2- breast cancer. By targeting PIK3CA mutations, drugs can prolong the progression-free survival of patients and reduce the risk of tumor spread.
When using Alpelisib, some side effects may occur. Understanding these possible adverse effects can help patients detect and take action early.
Medications can cause mouth sores or inflammation that manifests as pain, redness, or difficulty eating. Maintaining good oral hygiene and taking appropriate treatment measures can alleviate these symptoms.
Medications can cause a drop in blood calcium levels, affect bone density or trigger muscle cramps. These problems can be alleviated by supplementing with calcium or adjusting treatment regimens.
Now that we know about the side effects management of Alpelisib, we will introduce the drugs under the Lucius brand and related information.
The Lucius Pharmaceutical factory covers an area of about 25,000 square meters and is equipped with advanced modern production facilities and equipment. The company has a rich product line, covering many therapeutic fields such as anti-tumor drugs, cardiovascular drugs, hematology drugs, diabetes drugs, dermatology drugs, men's health drugs and anti-aging drugs, and has more than 200 generic drug varieties.
The company strictly follows the international Good Manufacturing Practice (GMP), from raw material procurement to the production process to the finished product inspection, every link is strictly controlled. Lucius has established a complete quality traceability system to ensure the controllability and traceability of drug quality.
After learning about Lucius Pharmaceutical's comprehensive product line and strict quality management, let's focus on the things that need special attention in the process of medication.
When using Alpelisib, please be aware of the following medication precautions for better management of the treatment process.
During treatment, pay close attention to diarrhea or colitis symptoms, such as abdominal pain, mucus, or bloody stools. Depending on the severity of symptoms, medications may need to be adjusted or stopped. In case of diarrhea, medical personnel should be notified, and antidiarrheal treatment should be carried out in time to increase fluid intake.
If the patient develops severe symptoms of hypersensitivity, such as rash, dyspnea, or facial swelling, Alpelisib should be discontinued immediately and the drug should be permanently discontinued. Patients should be aware of these symptoms and seek medical attention as soon as they occur.
[Warm tips] Please store the medicine in a cool, dry place, away from direct sunlight and humid environment.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:3492025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:5512024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:3362025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:3502025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:3262025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:3922025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:3252025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:3002025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643